Predicting Treatment Outcomes: The Case for Hypoxia Gene Signatures
- PMID: 29776747
- PMCID: PMC6020707
- DOI: 10.1016/j.ebiom.2018.05.016
Predicting Treatment Outcomes: The Case for Hypoxia Gene Signatures
References
-
- Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. - PubMed
-
- Mohler J., Bahnson R.R., Boston B., Busby J.E., D'Amico A., Eastham J.A. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw. 2010;8(2):162–200. - PubMed
-
- Marignol L., Coffey M., Lawler M., Hollywood D. Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev. 2008;34(4):313–327. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical